Form 4: Medpace Holdings Director Exercises Options and Sells Shares
SEC Form 4
Ashley M. Keating, a director at Medpace Holdings, exercised stock options and sold 500 shares of common stock on February 28, 2024.
Summary
- On February 28, 2024, Ashley M. Keating, a director of Medpace Holdings, Inc., exercised stock options to acquire 500 shares of common stock at a price of $54.99 per share.
- Simultaneously, Keating sold 500 shares of Medpace Holdings common stock at $405 per share.
- Following these transactions, Keating directly owns 472 shares of Medpace Holdings.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard Form 4 filing indicating insider trading activity, which doesn't inherently suggest positive or negative sentiment.
Industry Context
This is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The transaction could have a minor impact on shareholders due to the change in ownership, but it's unlikely to be significant given the relatively small number of shares involved.
- Employees are unlikely to be directly impacted by this transaction.
Key Dates
| Date | Description |
|---|---|
| 05/14/2020 | Option vested in full |
| 05/17/2026 | Expiration date of the stock option |
| 02/28/2024 | Date of transaction (option exercise and share sale) |
| 03/01/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.